bromouracil has been researched along with Sarcoma 37 in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
Sarcoma 37: An experimental sarcoma of mice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LANGEN, P | 1 |
| VENKER, P | 1 |
1 other study available for bromouracil and Sarcoma 37
| Article | Year |
|---|---|
[ON THE INCORPORATION OF BROMOURACIL INTO THE DESOXYRIBONUCLEIC ACID OF TUMOR-BEARING MICE BY ADMINISTRATION OF BROMOURACIL AND DESOXYGUANOSINE].
Topics: Animals; Bromouracil; Carcinoma; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Mice; Nucleosides; Re | 1963 |